Concise review: Therapeutic potential of flupirtine maleate

  • Nisha Kumari Yadav
  • Tripti Shukla School of Pharmacy & Research, Peoples University, Bhopal (M.P) 462037
  • Neeraj Upmanyu School of Pharmacy & Research, Peoples University, Bhopal (M.P) 462037
  • Sharad Prakash Pandey Shri Govindram Seksaria Institute of Technology and Science, Indore (M.P.) India
  • Mohammad Azaz Khan Pinnacle Biomedical Research Institute (PBRI), Bhopal, (M.P), 462003
  • Deepak Kumar Jain Medicinal Chemistry Research Laboratory, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas University, Bilaspur-495009, (CG) India

Abstract

Flupirtine is a non-opioid analgesic without antipyretic or antiphlogistic properties. Flupirtine is a centrally acting analgesic but the analgesic action of flupirtine does not depend on any central opioid effect. The fact behind this statement is that the pain-relieving property of flupirtine is not reduced by the opioid antagonistic drug naloxone. Flupirtine has been reported for its neuro-protective properties and possess a selective neuronal potassium channel opener that also has NMDA receptor antagonist properties. Flupertine is transformed into two primary derivatives, 4-fluoro-hippuric acid and the Nacetylated analogue D13223. Both derivatives of are flupirtine pharmacologically active with 30% of the analgesic potency of the parent drug and further oxidized and then conjugated with glycine to form inactive  metabolites, Recently, Flupirtine maleate  has been introduced in Indian market in oral, intravenous and rectal dosage forms. The half life of flupirtine following intravenous administration was 1.8 hours, while the plasma elimination half life in healthy young volunteers following single dose administration of flupirtine by the intravenous, oral and rectal routes was 8.5, 9.6 and 10.7 hours respectively. There is plenty of literature available on the effect of Flupirtine maleate on chronic and acute pain management. These preliminary finding require confirmation in further comparative studies.


Keywords: Flupirtine maleate, Naloxone, Opioid, NMDA

Downloads

Download data is not yet available.

Author Biographies

Tripti Shukla, School of Pharmacy & Research, Peoples University, Bhopal (M.P) 462037

School of Pharmacy & Research, Peoples University, Bhopal (M.P) 462037

Neeraj Upmanyu, School of Pharmacy & Research, Peoples University, Bhopal (M.P) 462037

School of Pharmacy & Research, Peoples University, Bhopal (M.P) 462037

Sharad Prakash Pandey, Shri Govindram Seksaria Institute of Technology and Science, Indore (M.P.) India

Shri Govindram Seksaria Institute of Technology and Science, Indore (M.P.) India

Mohammad Azaz Khan, Pinnacle Biomedical Research Institute (PBRI), Bhopal, (M.P), 462003

Pinnacle Biomedical Research Institute (PBRI), Bhopal, (M.P), 462003

Deepak Kumar Jain, Medicinal Chemistry Research Laboratory, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas University, Bilaspur-495009, (CG) India

Medicinal Chemistry Research Laboratory, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas University, Bilaspur-495009, (CG) India

Statistics
19 Views | 55 Downloads
How to Cite
Yadav, N. K., Shukla, T., Upmanyu, N., Pandey, S. P., Khan, M. A., & Jain, D. K. (2019). Concise review: Therapeutic potential of flupirtine maleate. Journal of Drug Delivery and Therapeutics, 9(1-s), 467-471. https://doi.org/10.22270/jddt.v9i1-s.2350